Anti-Human IL5RA Recombinant Antibody

Name: Anti-Human IL5RA Recombinant Antibody
Brand: KMD Bioscience
SKU: YR1226

YR1226

科研级 Benralizumab ( 苯拉组单抗 ), Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab

DATASHEET MSDS

Product Description

Alias	科研级 Benralizumab ( 苯拉组单抗 ), Anti-IL5RA Recombinant Antibody, Research Grade Benralizumab
Catalog Number	YR1226
Molecular Name	Benralizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1 Kappa
Formulation	PBS, pH7.5
Background	Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125). Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016. It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe eosinophilic asthma.
CAS Number	1044511-01-4
Application	WB, FCM, IP, ELISA, Neut, FuncS, IF
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	IL5RA[Homo sapiens]

Login